申请人:SMITHKLINE BEECHAM CORP
公开号:WO2010025087A1
公开(公告)日:2010-03-04
The invention described herein relates to certain pyrimidinedione N-substituted glycine derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
本发明涉及某些式(I)的嘧啶二酮N-取代甘氨酸衍生物,这些衍生物是HIF脯氨酸羟化酶的拮抗剂,可用于治疗受益于抑制该酶的疾病,贫血是其中的一个例子。